Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.620
+0.020 (1.25%)
At close: Dec 31, 2025, 4:00 PM EST
1.590
-0.030 (-1.85%)
After-hours: Dec 31, 2025, 7:11 PM EST
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $60.83 million as of December 31, 2025. Its market cap has decreased by -49.84% in one year.
Market Cap
60.83M
Enterprise Value
-81.63M
1-Year Change
-49.84%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $60.83M, a decrease of -89.19%. That is a compound annual growth rate of -69.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |